Goldman Sachs’s Trillium Therapeutics Inc. TRIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,263,721
| Closed | -$22.2M | – | 5854 |
|
|
2021
Q3 | $22.2M | Buy |
1,263,721
+762,279
| +152% | +$13.4M | ﹤0.01% | 1663 |
|
|
2021
Q2 | $4.86M | Buy |
501,442
+398,567
| +387% | +$3.87M | ﹤0.01% | 2807 |
|
|
2021
Q1 | $1.1M | Sell |
102,875
-142,467
| -58% | -$1.53M | ﹤0.01% | 3832 |
|
|
2020
Q4 | $3.61M | Buy |
245,342
+67,781
| +38% | +$997K | ﹤0.01% | 2679 |
|
|
2020
Q3 | $2.52M | Sell |
177,561
-24,272
| -12% | -$345K | ﹤0.01% | 2782 |
|
|
2020
Q2 | $1.63M | Buy |
201,833
+89,182
| +79% | +$722K | ﹤0.01% | 2943 |
|
|
2020
Q1 | $455K | Buy |
+112,651
| New | +$455K | ﹤0.01% | 3546 |
|